Medical News

RSS

Post-2015 must address poverty, food security

Mark Suzman, managing director for international policy, programs and advocacy at the Bill & Melinda Gates Foundation, writes in the foundation's "Impatient Optimists" blog, "Last week saw two key events related to the Millennium Development Goals: the kickoff on April 5 of an ambitious global campaign focused on accelerating progress over the last 1,000 days before the 2015 deadline and a critical meeting on April 4 in Madrid to assess how hunger, food security and nutrition should be tackled in any post-2015 framework."

11 Apr 2013

Study reveals new method to restore grip function in people with tetraplegia

A new method in which a number of operations are performed simultaneously can provide people with tetraplegia with a better grip function and the ability to open their hand. This method also shortens the patient's rehabilitation period by at least three months, reveals a doctoral thesis from the Sahlgrenska Academy, University of Gothenburg, Sweden.

11 Apr 2013

Computational simulations can help understand, treat cardiac rhythm disorders

Computational models of the human heart can be very useful in studying not just the basic mechanisms of heart function, but also to analyze the heart in a diseased state, and come up with methods for diagnosis and therapy.

11 Apr 2013

Reuters examines debate among non-profit groups over anti-prostitution pledge law

"A Supreme Court case that challenges a law requiring anti-prostitution policies for HIV/AIDS programs seeking federal money has generated a split among non-profit groups that counsel sex workers overseas," Reuters reports.

11 Apr 2013

Exposure to metabolic risks of cardiovascular disease increasing

Despite their greater life expectancy, the adults of today are less "metabolically" healthy than their counterparts of previous generations.

11 Apr 2013

Study: Using best-practice approach could lead to big cost reductions in hospitals nationwide

A major challenge facing today's health care community is to find ways to lower costs without compromising clinical quality. Taking that challenge to task, researchers at Medstar Health and Georgetown University School of Medicine, Washington DC, report success in using a concept called "value-based analysis," which simultaneously measures quality and cost and addresses inefficiencies in care.

11 Apr 2013

South Africa announces rollout of new single-dose ARV therapy

"South Africa's Health Minister Aaron Motsoaledi announced on Monday the launch of a new single-dose combination antiretroviral drug that will cost just 89 rand a month ($10) per patient, potentially revolutionizing AIDS treatment in the country," Salon reports (McDonough, 4/9).

11 Apr 2013

Reduction in neurogenesis associated with loss of certain cognitive faculties

These results incentivise the development of targeted therapies enabling improved neurone production to alleviate cognitive decline in the elderly and reduce the cerebral lesions caused by radiotherapy.

11 Apr 2013

New research suggests feeling powerful may protect against consequences of stereotype threat

New research from social psychologists at Indiana University Bloomington suggests that feeling powerful might protect against the debilitating effects of negative stereotypes.

11 Apr 2013

USAID marks 1,000 day milestone until 2015 MDG target date with digital conversations

"On April 5, USAID joined U.N. Foundation's Momentum 1000 and millions around the globe in a digital rally to mark the 1,000 day milestone until the 2015 target date to achieve the United Nations Millennium Development Goals: A promise made to free people from extreme poverty and extend hope and opportunity to the millions living in developing regions," the agency's "IMPACTblog" writes.

11 Apr 2013

New research finds HPV plays role in lung cancer in some patients

A common virus known to cause cervical and head and neck cancers may also trigger some cases of lung cancer, according to new research presented by Fox Chase Cancer Center at the AACR Annual Meeting 2013 on Wednesday, April 10.

11 Apr 2013

People who practice sport have better cognitive performance, researchers say

New scientific evidence seems to confirm the famous Roman saying "Mens sana in corpore sano". Researchers from the University of Granada have demonstrated that people who normally practice sport have a better cognitive performance than those with bad physical health.

11 Apr 2013

Tavenner moves closer to Senate confirmation to head CMS

Marilyn Tavenner, who has been the acting administrator of the Centers for Medicare & Medicaid Services since 2011, received a warm reception from Democrats and Republicans alike during a Tuesday Senate Finance Committee hearing.

11 Apr 2013

DelMar Pharmaceuticals reports positive results from VAL-083 Phase I/II clinical trial in patients with GBM

DelMar Pharmaceuticals, Inc. today announced additional positive interim data from an ongoing Phase I/II clinical trial of VAL-083 in patients with recurrent glioblastoma multiforme (GBM) or progressive secondary brain tumor.

11 Apr 2013

BioLineRx gets regulatory approvals in US to start BL-8040 Phase IIa trial for treatment of AML

BioLineRx, a biopharmaceutical development company, announced today that it has received all necessary regulatory approvals in the US to commence a Phase IIa trial for BL-8040, for the treatment of Acute Myeloid Leukemia.

11 Apr 2013

Viewpoints: Obama budget doesn't address 'heart of our debt crisis;' Attention deficit crisis; Insurer sings a different song when consumer owes it money

The U.S. has huge budget challenges. And for the first time in years, we will have three budget proposals to carefully consider -- instead of speeches and talking points.

11 Apr 2013

ImmunoGen discloses preclinical data for EGFR-targeting ADC, IMGN289

ImmunoGen, Inc., a biotechnology company that develops targeted anticancer therapeutics using its Targeted Antibody Payload technology, disclosed for the first time today preclinical data for its EGFR-targeting ADC, IMGN289.

11 Apr 2013

Updated clinical data from phase I study of Ensituximab presented at AACR meeting

Precision Biologics announced today that in conjunction with researchers from Precsion Biologics , Johns Hopkins Medical Center and Duke University Medical Center presented updated clinical data from the phase I study of Ensituximab, a novel therapeutic antibody to treat pancreas and colorectal cancers

11 Apr 2013

The truth about the 2 percent Medicare sequestration cuts

News outlets examine what can be done about cuts to Medicare payments to cancer clinics, among others. And the IPAB deadline is three weeks away.

11 Apr 2013

FDA accepts Merck's NDA for NOXAFIL tablets

Merck, known as MSD outside the United States and Canada, today announced that its New Drug Application for an investigational, tablet formulation of the company's antifungal agent, NOXAFIL (posaconazole), has been accepted for review by the U.S. Food and Drug Administration.

11 Apr 2013

Medical News

Post-2015 must address poverty, food security

Study reveals new method to restore grip function in people with tetraplegia

Computational simulations can help understand, treat cardiac rhythm disorders

Reuters examines debate among non-profit groups over anti-prostitution pledge law

Exposure to metabolic risks of cardiovascular disease increasing

Study: Using best-practice approach could lead to big cost reductions in hospitals nationwide

South Africa announces rollout of new single-dose ARV therapy

Reduction in neurogenesis associated with loss of certain cognitive faculties

New research suggests feeling powerful may protect against consequences of stereotype threat

USAID marks 1,000 day milestone until 2015 MDG target date with digital conversations

New research finds HPV plays role in lung cancer in some patients

People who practice sport have better cognitive performance, researchers say

Tavenner moves closer to Senate confirmation to head CMS

DelMar Pharmaceuticals reports positive results from VAL-083 Phase I/II clinical trial in patients with GBM

BioLineRx gets regulatory approvals in US to start BL-8040 Phase IIa trial for treatment of AML

Viewpoints: Obama budget doesn't address 'heart of our debt crisis;' Attention deficit crisis; Insurer sings a different song when consumer owes it money

ImmunoGen discloses preclinical data for EGFR-targeting ADC, IMGN289

Updated clinical data from phase I study of Ensituximab presented at AACR meeting

The truth about the 2 percent Medicare sequestration cuts

FDA accepts Merck's NDA for NOXAFIL tablets

How agentic AI is reshaping laboratory workflows

Fourier 80: bringing benchtop NMR systems to the laboratory

How industrial hygiene flow calibration supports defensible exposure data

Latest News